Childrens Allegra Hives

Manufacturer
Chattem, Inc.
Effective date
2026-05-01
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:55:59

Label at a glance#

ProductChildrens Allegra Hives
Active ingredientFEXOFENADINE HYDROCHLORIDE
Label structure10 sections

Indications and uses

reduces hives and relieves itching due to hives (urticaria). This product will not prevent hives or an allergic skin reaction from occurring.

Dosage and administration

■ shake well before using ■ use only with enclosed dosing cup adults and children 12 years of age and over take 10 mL every 12 hours; do not take more than 20 mL in 24 hours children 6 to under 12 years of age take 5 mL every 12 hours; do not take more than 10 mL in 24 hours children under 6 years of age ask a doctor adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctor Note: mL=...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Children’s Allegra Hives 12 HR oral suspension - Grape Flavor

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

(in each 5 mL)                                 

Fexofenadine HCl 30 mg

Purpose

OTC - PURPOSE SECTION

Antihistamine

Uses  

INDICATIONS & USAGE SECTION

reduces hives and relieves itching due to hives (urticaria).

This product will not prevent hives or an allergic skin reaction from occurring.

Warnings

WARNINGS SECTION

Severe Allergy Warning: Get emergency help immediately if you have hives along with any of the following symptoms: ■ swelling of tongue ■ trouble swallowing ■ swelling in or around mouth ■ trouble speaking

■ wheezing or problems breathing ■ drooling ■ dizziness or loss of consciousness

These symptoms may be signs of anaphylactic shock. This condition can be life threatening if not treated by a health professional immediately. Symptoms of anaphylactic shock may occur when hives first appear or up to a few hours later.

Not a Substitute for Epinephrine. If your doctor has prescribed an epinephrine injector for “anaphylaxis” or severe allergy symptoms that could occur with your hives, never use this product as a substitute for the epinephrine injector. If you have been prescribed an epinephrine injector, you should carry it with you at all times.

Do not use

OTC - DO NOT USE SECTION

■ to prevent hives from any known cause such as:

   ■ foods ■ insect stings ■ medicines ■ latex or rubber gloves

   because this product will not stop hives from occurring.

   Avoiding the cause of your hives is the only way to prevent them. Hives can sometimes be serious. If you do not

   know the cause of your hives, see your doctor for a medical exam. Your doctor may be able to help you find a

   cause.

■ if you have ever had an allergic reaction to this product or any of its ingredients 

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

■ kidney disease. Your doctor should determine if you need a different dose.

■ hives that are an unusual color, look bruised or blistered

■ hives that do not itch 

When using this product

OTC - WHEN USING SECTION

■ do not take more than directed  

■ do not take at the same time as aluminum or magnesium antacids

■ do not take with fruit juices (see Directions)

Stop use and ask a doctor if  

OTC - STOP USE SECTION

■ an allergic reaction to this product occurs. Seek medical help right away.  

■ symptoms do not improve after 3 days of treatment

■ the hives have lasted more than 6 weeks

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use. 

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions  

DOSAGE & ADMINISTRATION SECTION

■ shake well before using ■ use only with enclosed dosing cup

adults and children 12 years of age and overtake 10 mL every 12 hours; do not take more than 20 mL in 24 hours
children 6 to under 12 years of agetake 5 mL every 12 hours; do not take more than 10 mL in 24 hours
children under 6 years of ageask a doctor
adults 65 years of age and olderask a doctor
consumers with kidney diseaseask a doctor
Note: mL= milliliters

Other information

SPL UNCLASSIFIED SECTION

■ each 5 mL contains: potassium 5 mg and sodium 19 mg

■ safety sealed: do not use if carton is opened or if printed foil inner seal on bottle is torn or missing

■ store between 20º and 25ºC (68º and 77ºF)

■ color change from white to beige is expected over time. This does not impact product effectiveness and safety.

Inactive ingredients   

INACTIVE INGREDIENT SECTION

edetate disodium, flavor, poloxamer 407, potassium sorbate, propylene glycol, purified water, sodium phosphate dibasic heptahydrate, sodium phosphate monobasic monohydrate, sucrose, titanium dioxide, xanthan gum, xylitol

Questions or comments?

OTC - QUESTIONS SECTION

call 1-8 66 - 844 - 2798

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 41167-4227-1
Childrens Allegra Hives

Grape Flavor
30 mg/5 mL antihistamine

Grape
12 HR
240 mL

NDC 41167-4227-1 Childrens Allegra Hives Grape Flavor 30 mg/5 mL antihistamine Grape 12 HR 240 mLNDC 41167-4227-1 Childrens Allegra Hives Grape Flavor 30 mg/5 mL antihistamine Grape 12 HR 240 mL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
997491fexofenadine HCl 30 MG in 5 mL Oral SuspensionPSN1
997491fexofenadine hydrochloride 6 MG/ML Oral SuspensionSCD1
997491fexofenadine HCl 30 MG per 5 ML Oral SuspensionSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
FEXOFENADINE Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508
b893258d-0942-3d8a-3411-056ea0788ff5Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
41167-4227-1Childrens Allegra Hives1 in 1 CARTONSUSPENSION11
41167-4227-1Childrens Allegra Hives240 mL in 1 BOTTLE, PLASTICSUSPENSION2401

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
41167-422741167-4227-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N201373-001CHILDREN'S ALLEGRA ALLERGYFEXOFENADINE HYDROCHLORIDE30MG/5MLSUSPENSION / ORALRLD, RS2011-01-24
N201373-002CHILDREN'S ALLEGRA HIVESFEXOFENADINE HYDROCHLORIDE30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION / ORALRLD2011-01-24

Orange Book patents#

Current patent rows page 1 of 1 · 2 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N201373-00189330972030-08-02Drug product2015-02-19
N201373-00289330972030-08-02Drug product2015-02-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-2484e616aacf4f…
2026-09-14 22:38:342026-08N201373-002CHILDREN'S ALLEGRA HIVES30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION / ORALRLD2011-01-2484e616aacf4f…
2026-08-18 06:07:402026-07N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-24caaa826d4ba7…
2026-08-18 06:07:402026-07N201373-002CHILDREN'S ALLEGRA HIVES30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION / ORALRLD2011-01-24caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-24011fe1cb6892…
2026-02-19 14:30 UTC2026-02N201373-002CHILDREN'S ALLEGRA HIVES30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION / ORALRLD2011-01-24011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-2431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N201373-002CHILDREN'S ALLEGRA HIVES30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION / ORALRLD2011-01-2431067a03dcf5…
2025-08-23 18:47 UTC2025-08N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-246a471c1ec25d…
2025-08-23 18:47 UTC2025-08N201373-002CHILDREN'S ALLEGRA HIVES30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION / ORALRLD2011-01-246a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-24fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N201373-002CHILDREN'S ALLEGRA HIVES30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION / ORALRLD2011-01-24fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-24b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N201373-002CHILDREN'S ALLEGRA HIVES30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION / ORALRLD2011-01-24b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-2403ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N201373-002CHILDREN'S ALLEGRA HIVES30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION / ORALRLD2011-01-2403ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-242680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N201373-002CHILDREN'S ALLEGRA HIVES30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION / ORALRLD2011-01-242680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-245bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N201373-002CHILDREN'S ALLEGRA HIVES30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION / ORALRLD2011-01-245bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-24d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N201373-002CHILDREN'S ALLEGRA HIVES30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION / ORALRLD2011-01-24d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-24d06236e962d9…
2024-10-29 15:01 UTC2024-10N201373-002CHILDREN'S ALLEGRA HIVES30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION / ORALRLD2011-01-24d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-2479d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N201373-002CHILDREN'S ALLEGRA HIVES30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION / ORALRLD2011-01-2479d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-24301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N201373-002CHILDREN'S ALLEGRA HIVES30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION / ORALRLD2011-01-24301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-241e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N201373-002CHILDREN'S ALLEGRA HIVES30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION / ORALRLD2011-01-241e350fbaab3a…
2024-05-31 18:47 UTC2024-05N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-248072bd15b7f6…
2024-05-31 18:47 UTC2024-05N201373-002CHILDREN'S ALLEGRA HIVES30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION / ORALRLD2011-01-248072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-245c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N201373-002CHILDREN'S ALLEGRA HIVES30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION / ORALRLD2011-01-245c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-245d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N201373-002CHILDREN'S ALLEGRA HIVES30MG/5MLSUSPENSION / ORALRLD2011-01-245d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-244b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N201373-002CHILDREN'S ALLEGRA HIVES30MG/5MLSUSPENSION / ORALRLD2011-01-244b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N201373-001CHILDREN'S ALLEGRA ALLERGY30MG/5MLSUSPENSION / ORALRLD, RS2011-01-2474a2ff9319b5…
2019-12-13 00:20 UTC2019-12N201373-002CHILDREN'S ALLEGRA HIVES30MG/5MLSUSPENSION / ORALRLD2011-01-2474a2ff9319b5…

Observed Orange Book patent history#

Patent history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-09-14 22:38:342026-08N201373-00189330972030-08-02Drug product2015-02-1984e616aacf4f…
2026-09-14 22:38:342026-08N201373-00289330972030-08-02Drug product2015-02-1984e616aacf4f…
2026-08-18 06:07:402026-07N201373-00189330972030-08-02Drug product2015-02-19caaa826d4ba7…
2026-08-18 06:07:402026-07N201373-00289330972030-08-02Drug product2015-02-19caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N201373-00189330972030-08-02Drug product2015-02-19011fe1cb6892…
2026-02-19 14:30 UTC2026-02N201373-00289330972030-08-02Drug product2015-02-19011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N201373-00189330972030-08-02Drug product2015-02-1931067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N201373-00289330972030-08-02Drug product2015-02-1931067a03dcf5…
2025-08-23 18:47 UTC2025-08N201373-00189330972030-08-02Drug product2015-02-196a471c1ec25d…
2025-08-23 18:47 UTC2025-08N201373-00289330972030-08-02Drug product2015-02-196a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N201373-00189330972030-08-02Drug product2015-02-19fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N201373-00289330972030-08-02Drug product2015-02-19fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N201373-00189330972030-08-02Drug product2015-02-19b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N201373-00289330972030-08-02Drug product2015-02-19b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N201373-00189330972030-08-02Drug product2015-02-1903ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N201373-00289330972030-08-02Drug product2015-02-1903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N201373-00189330972030-08-02Drug product2015-02-192680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N201373-00289330972030-08-02Drug product2015-02-192680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N201373-00189330972030-08-02Drug product2015-02-195bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N201373-00289330972030-08-02Drug product2015-02-195bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N201373-00189330972030-08-02Drug product2015-02-19d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N201373-00289330972030-08-02Drug product2015-02-19d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N201373-00189330972030-08-02Drug product2015-02-19d06236e962d9…
2024-10-29 15:01 UTC2024-10N201373-00289330972030-08-02Drug product2015-02-19d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N201373-00189330972030-08-02Drug product2015-02-1979d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N201373-00289330972030-08-02Drug product2015-02-1979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N201373-00189330972030-08-02Drug product2015-02-19301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N201373-00289330972030-08-02Drug product2015-02-19301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N201373-00189330972030-08-02Drug product2015-02-191e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N201373-00289330972030-08-02Drug product2015-02-191e350fbaab3a…
2024-05-31 18:47 UTC2024-05N201373-00189330972030-08-02Drug product2015-02-198072bd15b7f6…
2024-05-31 18:47 UTC2024-05N201373-00289330972030-08-02Drug product2015-02-198072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N201373-00189330972030-08-02Drug product2015-02-195c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N201373-00289330972030-08-02Drug product2015-02-195c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N201373-00189330972030-08-02Drug product2015-02-195d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N201373-00289330972030-08-02Drug product2015-02-195d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N201373-00189330972030-08-02Drug product2015-02-194b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N201373-00289330972030-08-02Drug product2015-02-194b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N201373-00189330972030-08-02Drug product2015-02-1974a2ff9319b5…
2019-12-13 00:20 UTC2019-12N201373-00289330972032-08-16Drug product2015-02-1974a2ff9319b5…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Childrens Allegra HivesFEXOFENADINE HCLChattem, Inc.ff50d9cd-d849-43e8-b32a-4dcde798d3eb2026-05-01WarningsExact identifier
ndc (package): 41167-4227-1
ndc (product): 41167-4227
ndc11 (package): 41167422701
spl id: 37df2ad5-479f-4534-b550-e42479a3b2db
spl set id: ff50d9cd-d849-43e8-b32a-4dcde798d3eb

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.